BioAtla BCAB
OTC BCAB
$1.50 -0.10 (-6.25%)
At close: Sep 29, 2026 · 4:00 PM EDT

BioAtla (BCAB) Asset Utilization Ratio (2021 - 2026)

Updated

BioAtla's Asset Utilization Ratio was 0.94 in Q2 2026, up 179.7% from 0.34 a year earlier.

Analysis

BioAtla (BCAB) Asset Utilization Ratio (2021 - 2026) Analysis & Trends

For FY2025, Asset Utilization Ratio at BioAtla came in at 0.06, down 52.8% from FY2024.

  • In earlier years, Asset Utilization Ratio was 0.13 in FY2024 and 0.00 in FY2021.
  • The Q2 2026 figure marks the highest quarterly Asset Utilization Ratio in data going back to Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 0.49
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 0.47
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 0.52
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 0.44
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 0.53
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 0.40
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 0.58
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 0.47
10 BioAtla 2.49 Mn 2.49 Mn - 0.94
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.94
Dec 31, 2025 0.13
Sep 30, 2025 0.51
Jun 30, 2025 0.34
Dec 31, 2024 0.19
Sep 30, 2024 0.17
Sep 30, 2023 0.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Jun 30, 2021 0.00
Mar 31, 2021 0.00
API Access

BioAtla Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=BCAB&period=max&api_key=YOUR_API_KEY